DEXCOM, INC. DXCM Cash Flow

Dexcom, inc. (DXCM)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09
Operating activities
Net Income (Loss) Attributable to Parent
101,100	-127,100	-50,200	-65,600	-57,600	-22,400	-29,800	-54,500	-44,700	-55,200	-53,524
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization
48,700	29,100	16,100	15,000	10,800	8,400	7,000	6,600	3,800	2,400	2,373
Share-based compensation
102,700	101,900	106,200	110,800	82,700	50,000	24,600	18,400	13,500	9,400	8,366
Non-cash restructuring charge
-	-	-	-	-	-	-	-	-	-	-362
Accretion and amortization related to marketable securities, net
-	-	-	-	-	-	-300	-800	-900	-700	-891
Non-cash interest expense
49,600	17,900	9,400	100	200	-	-	-	-	1,100	4,861
Non-cash collaborative research and development fee through issuance of common stock
0	217,700	0	0	36,500	0	0	-	-	-	-
Unrealized gain on equity investment
0	36,000	0	0	-	-	-	-	-	-	-
Less: Net gains recognized during the period on equity securities sold during the period
-	-	-	0	-	-	-	-	-	-	-
Realized loss on equity investment
-4,200	44,100	0	-	-	-	-	-	-	-	-
Loss on disposal of equipment
-	-	-	-	-	-	-	-	-	-100	0
Other non-cash income and expenses
-2,100	-4,700	-7,900	-2,200	800	200	200	0	0	-	-
Impairment of Intangible Assets, Finite-lived
-	-	-	-	-	200	-	0	-	-	-
Release of valuation allowance against deferred tax assets
-	-	-	-	-	-	-	1,300	0	0	-
Change in fair value of contingent consideration
-	-	-	-	-	-	2,500	700	0	0	-
Loss on debt extinguishment upon conversion of convertible debt
-	-	-	-	-	-	-	-	-	-8,500	0
Amortization of debt issuance costs
-	-	-	-	-	-	400	100	0	0	246
Changes in operating assets and liabilities:
Accounts receivable, net
60,000	93,200	31,800	27,200	31,700	16,300	6,500	7,000	5,900	3,200	2,372
Inventory
49,100	25,500	-400	9,800	19,200	7,000	1,600	-700	100	5,400	195
Prepaid and other assets
7,200	3,000	6,700	3,900	2,500	400	1,400	800	-1,200	-1,300	1,004
Operating lease right-of-use assets and liabilities, net
2,400	0	0	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-1,000	0	0	-100	800	700	1,856
Accounts payable and accrued liabilities
109,000	56,200	21,100	21,100	17,800	8,300	2,400	300	1,000	-400	1,508
Accrued payroll and related expenses
16,000	23,800	14,800	8,500	7,700	2,200	5,800	2,400	1,100	1,300	2,291
Deferred revenue
-	-	-	-	100	0	-1,200	100	-1,600	-4,200	-4,275
Deferred revenue and other liabilities
-200	800	4,800	5,000	2,400	400	-300	500	-100	200	-49
Net cash provided by operating activities
314,500	123,200	92,000	56,200	49,000	23,600	2,400	-33,100	-30,100	-42,700	-39,389
Cash flows from investing activities:
Purchases of marketable securities
2,030,400	452,500	171,800	39,200	45,200	13,800	16,300	66,400	102,700	73,400	65,270
Proceeds from sale and maturity of marketable securities
1,196,400	392,100	93,400	38,700	27,500	13,200	45,100	104,300	64,300	54,700	53,856
Purchases of other equity investments
1,200	1,000	0	0	-	-	-	-	-	-	-
Purchases of property and equipment
180,000	67,100	66,000	55,700	33,300	16,200	7,900	9,500	8,000	6,900	2,992
Acquisitions, net of cash acquired
0	11,300	0	-300	500	0	0	-	-	-	-
Proceeds from the sale of equipment
-	-	-	-	-	-	-	-	-	-	302
Net cash provided by investing activities
-1,015,200	-139,800	-144,400	-55,900	-51,500	-16,800	20,900	28,400	-46,400	-25,600	-14,104
Cash flows from financing activities:
Net proceeds from issuance of common stock
11,900	10,800	10,100	10,400	19,100	24,000	12,000	3,600	74,700	70,500	46,310
Purchases of treasury stock
0	100,000	0	0	-	-	-	-	-	-	-
Proceeds from issuance of convertible debt, net of issuance costs
0	836,600	389,000	0	0	-	-	-	-	-	-
Proceeds from sale of warrants
0	183,800	0	0	-	-	-	-	-	-	-
Purchase of convertible note hedge
0	218,900	0	0	-	-	-	-	-	-	-
Proceeds from short-term borrowings
0	0	75,000	0	0	-	-	-	-	-	-
Repayment of short-term borrowings
0	0	75,000	0	0	-	-	-	-	-	-
Other financing activities
-1,200	-1,900	0	-2,300	-	-	-	-	-	-	-
Proceeds from Issuance of Long-term Debt
-	-	-	-	-	-	-	6,600	0	0	-
Repayment of long-term debt
-	-	-	-	2,300	2,200	200	0	0	-	-
Repayments of Secured Debt
-	-	-	-	-	-	-	-	500	900	1,931
Net cash provided by financing activities
10,700	710,400	399,100	8,100	16,800	21,800	11,800	10,200	74,200	69,600	44,379
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-700	1,800	300	0	0	-	-	-	-	0	-9
Increase in cash, cash equivalents and restricted cash
-690,700	695,600	347,000	8,400	14,300	28,600	35,100	5,500	-2,300	1,300	-9,123
Supplemental disclosure of non-cash investing and financing transactions:
Issuance of common stock in connection with acquisition
-	-	-	7,200	0	0	-	6,100	0	-	-
Acquisition-related holdback liability
-	-	-	-	0	0	-	-	-	-	-
Assets acquired and financing obligation under build-to-suit leasing arrangement
-	-	-	6,000	0	0	-	-	-	-	-
Acquisition of property and equipment included in accounts payable and accrued liabilities
14,200	10,800	6,300	10,500	2,900	-	-	-	-	-	-
Cash paid during the year for interest
10,400	3,600	2,400	100	300	400	500	0	0	400	2,932
Cash paid during the year for income taxes
4,800	2,300	1,400	100	100	0	-	-	-	-	-
Other Significant Noncash Transaction, Value of Sweetspot Contingent Conisederation Settlement
-	-	-	-	-	4,000	0	0	-	-	-
Unrealized gain (loss) on marketable securities
-	-	-	-	-	-	-	-	-	-	-54
Conversion of convertible notes to common stock
-	-	-	-	-	-	-	-	-	46,300	0